US FDA eliminates risk evaluation and mitigation strategies for CAR-T cancer therapies

reuters.com/business/healthcare-pharmaceuticals/us-fda-eliminates-risk-evaluation-mitigation-strategies-car-t-cancer-therapies-2025-06-27

This story appeared on reuters.com, 2025-06-27 20:37:15.487000.
The Entire Business World on a Single Page. Free to Use →